Skip to main content
Clinical Trials/JPRN-UMIN000018130
JPRN-UMIN000018130Recruiting未知

Efficacy of memantine treatment for the prevention and restration to cognitive dysfunction in patients receiving radiochemotherapy combined with hyperbaric oxygenation - Efficancy of memantine treatment in cognitive dysfunction of patients with malignant gliomas

Department of neurosurgery, Graduate school of medicine, University of Ryukyus0 sites30 target enrollmentStarted: July 31, 2015Last updated:

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1.Patient with hypersensitivity for memantine 2.Patients with renal dysfunction 3.Patients with having factor ascend urinary pH 4.Patients with hepatic insufficiency 5.Patients with pregnancy 6.Patients who need the continuous medication having drug interact with memantine 7.Patients who were judged by doctors as not being appropriate subjects

Investigators

Sponsor
Department of neurosurgery, Graduate school of medicine, University of Ryukyus

Similar Trials